s Dr. Kocis has been involved in the drug discovery research in cancer, immunodeficiencies, CNS and asthma, and provided drug lead discovery leadership at Hoechst-Marion-Roussell, Zeneca Pharmaceuticals and AstraZeneca, most recently as the Global Head of AstraZeneca Discovery Capabilities & Sciences, Exploratory Chemistry. At AstraZeneca, Dr. Kocis built a global organization with the remit of generating proprietary chemotypes and building blocks, which contributed to the development of several clinical candidates including templates present in Iressa®, Zactima® and other medicines. Dr. Kocis also led the development of company-wide criteria for medicinally relevant compounds and the development of AstraZeneca compo

 s Dr. Kocis has been involved in the drug discovery research in cancer, immunodeficiencies, CNS and asthma, and provided drug lead discovery leadership at Hoechst-Marion-Roussell, Zeneca Pharmaceuticals and AstraZeneca, most recently as the Global Head of AstraZeneca Discovery Capabilities & Sciences, Exploratory Chemistry. At AstraZeneca, Dr. Kocis built a global organization with the remit of generating proprietary chemotypes and building blocks, which contributed to the development of several clinical candidates including templates present in Iressa®, Zactima® and other medicines. Dr. Kocis also led the development of company-wide criteria for medicinally relevant compounds and the development of AstraZeneca compo